Agenus announces peer-reviewed publication on BOT+BAL in MSS metastatic CRC
Agenus says a peer-reviewed publication links BOT+BAL’s durable survival in MSS metastatic colorectal cancer to its immune-priming mechanism.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.